⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
TrueLab Biopharmaceutical gibt Lizenzvereinbarung mit Bionyra Pharma über zwei monoklonale und bispezifische Antikörper der nächsten Generation zur Behandlung immunvermittelter Entzündungskrankheiten im Wert von bis zu 985 Millionen US-Dollar bekannt
prnewswire.com
SNY
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
prnewswire.com
BFLY
SNY
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases
businesswire.com
SNY
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
globenewswire.com
SNY
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
globenewswire.com
SNY
Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé
globenewswire.com
SNY
COUR Pharma Announces Closing of $50 Million Series B
globenewswire.com
SNY
PFE
Collibra Named Databricks' Governance Partner of the Year; Collibra and Databricks Deepening a Partnership to Ground Agentic AI in Governed Context
prnewswire.com
RIVN
MA
BABA
UBER
CMG
ADI
AMZN
GOOG
MSFT
NVDA
CRM
PYPL
IBM
INTC
ADBE
NFLX
HON
GE
BA
CAT
UNH
PEP
KO
MCD
COST
WMT
TMO
ABBV
XOM
CVX
JPM
BAC
WFC
C
GS
MS
DIS
CMCSA
VZ
T
SBUX
NKE
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
PG
LMT
RTX
GD
LRCX
MU
AMD
QCOM
TXN
AVGO
AMAT
KLAC
ASML
ENPH
CRSP
REGN
VRTX
BIIB
AZN
SNY
LLY
BNTX
XCUR
ALGN
TDOC
ZBRA
ROKU
UL
AI-Driven Bispecific Antibody Development Attracts $1+ Billion in Pharma Investments Amid Clinical Risk Mitigation Focus
globenewswire.com
SNY
PFE
AMGN
REGN
Next Generation Drug Conjugates Market Expected to Reach USD 42.55 Billion by 2035 | MarketsandMarkets™
globenewswire.com
AZN
NVS
ALNY
GILD
ABBV
IONS
SNY